-
-
-
-
-
-
-
Canaccord Genuity Starts Kiniksa (KNSA) at Buy
-
-
-
-
-
-
-
Kiniksa Pharmaceuticals Ltd. (KNSA) 5K contracts of October 30 calls trade, share price up 12.5%
-
-
-
-
-
-
-
Kiniksa Pharmaceuticals (KNSA) Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
-
-
-
416,816 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

